PHARMA - March 2020
Where to publish: OA Institute - Launch Course Below
Learning Objectives
- Be aware of the advantages associated with glaucoma community collaborative care programs avail able in Australia
- Gain a better understanding of the therapeutic management of some autoimmune/systemic conditions via the use of hydroxychloroquine and the associated ocular side effects this medication can produce
- Become more familiar with pigmented choroidal lesions in order to better understand which can be monitored and which should be referred for ophthalmological evaluation
- Become more familiar with the effects of pregnancy on the eyes and the relative safety of the various topical medications during pregnancy
- Gain a better understanding of a GP's approach into the investigation and management of various systemic conditions which can have ocular manifestations
- Become more familiar with the steps involved in the compounding of therapeutic medications
- Become more familiar with the difference in the accuracy of pterygium diagnosis between Australian GPs & optometrists
- Gain an understanding of how to access more advanced therapeutic dry eye management options within Australia
- Become more familiar with the ingredients and mechanism of action of NovaTears in the therapeutic management of dry eye
Max points awarded: 6.00
Session Information
| Name |
|---|
| PHARMA - March 2020 |
| Activity Type |
| Independent Learning with Assessment |
| Therapeutic? |
| Yes |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 4.00 |
| Name |
|---|
| PHARMA - March 2020 |
| Activity Type |
| Independent Learning with Assessment |
| Therapeutic? |
| No |
| Manufacturer/Supplier? |
| No |
| Points for attending & Passing Assessment |
| 2.00 |